DIABETES & PANCREATITIS Placental Insufficiency Decreases Pancreatic Vascularity and Disrupts Hepatocyte Growth Factor Signaling in the Pancreatic Islet Endothelial Cell in Fetal Sheep Investigators determined the impact of intrauterine growth restriction on pancreatic vascularity and paracrine signaling between the pancreatic islet endothelial cell and β-cell. [Diabetes] Abstract Loss of TRB3 Alters Dynamics of MLK3-JNK Signaling and Inhibits Cytokine-Activated Pancreatic Beta Cell Death Researchers show that genetic deletion of TRB3 results in a basal activation of AKT, preserves mitochondrial integrity, and confers resistance to cytokine-induced pancreatic beta cell death. Mechanistically, they found that TRB3 stabilizes MLK3, most likely by suppressing AKT-directed phosphorylation, ubiquitination and proteasomal degradation of MLK3. [J Biol Chem] Abstract | Full Article In Vitro Reprogramming of Pancreatic Alpha Cells towards a Beta Cell Phenotype following Ectopic HNF4α Expression Scientists investigated whether hepatocyte nuclear factor 4 alpha (HNF4α), a transcription factor essential for a normal beta cell phenotype, could induce the reprogramming of alpha cells towards potential beta cells. [Mol Cell Endocrinol] Abstract Epiplakin Deficiency Aggravates Murine Caerulein-Induced Acute Pancreatitis and Favors the Formation of Acinar Keratin Granules Scientists analyzed epiplakin’s expression in healthy and inflamed pancreatic tissue and compared wild-type and epiplakin-deficient mice during caerulein-induced acute pancreatitis. They found that epiplakin was expressed primarily in ductal cells of the pancreas and colocalized with apicolateral keratin bundles in murine pancreatic acinar cells. [PLoS One] Full Article PANCREATIC CANCER CD166/ALCAM Expression Is Characteristic of Tumorigenicity and Invasive and Migratory Activities of Pancreatic Cancer Cells Researchers aimed to clarify the role and significance of CD166 expression in pancreatic cancer. The differences between isolated CD166+ and CD166– pancreatic cancer cells were analyzed by invasion and migration assays, and in mouse xenograft models. [PLoS One] Full Article Arginine Deiminase Augments the Chemosensitivity of Argininosuccinate Synthetase-Deficient Pancreatic Cancer Cells to Gemcitabine via Inhibition of NF-KappaB Signaling Investigators evaluated the therapeutic efficacy of arginine deiminase in combination with gemcitabine, the first line chemotherapeutic drug for patients with pancreatic cancer, and identified the mechanisms associated with its anticancer effects. [BMC Cancer] Abstract | Full Article Immunohistochemical Analysis of Cancer Stem Cell Markers in Pancreatic Adenocarcinoma Patients after Neoadjuvant Chemoradiotherapy Scientists examined the sequential changes in cancer stem cell marker expressions after neoadjuvant chemoradiotherapy in patients with pancreatic adenocarcinoma and the impact of these changes on the prognosis. [BMC Cancer] Abstract | Full Article Neurotrophic Factor Artemin Promotes Invasiveness and Neurotrophic Function of Pancreatic Adenocarcinoma In Vivo and In Vitro Researchers investigated the effect of the neurotrophic factor Artemin on neuroplasticity and perineural invasion of pancreatic adenocarcinoma. Artemin overexpression and RNA interference in the pancreatic cancer cell lines were performed to evaluate the effects of Artemin on cell proliferation, invasion, and neurotrophic activity in vitro and in nude orthotopic transplantation tumor models. [Pancreas] Abstract | Download Full Article Cytotoxicity of Gemcitabine Enhanced by Polyphenolics from Aronia melanocarpa in Pancreatic Cancer Cell Line AsPC-1 Extending work with brain tumors, the hypothesis that micronutrients may usefully augment anticancer regimens, chokeberry (Aronia melanocarpa) extract was tested to establish whether it has pro-apoptotic effects in AsPC-1, an established human pancreatic cell line, and whether it potentiates cytotoxicity in combination with gemcitabine. [J Clin Pathol] Full Article | Press Release |